http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0019999-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_032c44fba5f2d1f24fa859b63d2fb99d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e605f8532ed22817218f55853516e474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96add81d44642d097c8d7b129ec4d826
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
filingDate 1999-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4abec1f304ba985dac1c81f7baf7f598
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28b15c20cd8d811c679b777b3bb8b496
publicationDate 2000-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0019999-A1
titleOfInvention Fulvic acid and its use in the treatment of various conditions
abstract A pharmaceutical composition comprising a fulvic acid, salt, ester or derivative thereof as an active ingredient is disclosed. The composition is preferably administered orally or topically for treating a condition in a human or an animal. The condition may, for example, be inflammation, acne, eczema or bacterial or fungal or viral infections.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114910-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020187803-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007125492-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007125492-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011023970-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013132444-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9820953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017102565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010082182-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017146792-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006064449-A1
priorityDate 1998-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2850685-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9749288-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H119674-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0687752-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2244215-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5018304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127715174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID499950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23619366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128986543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128519904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129479103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135737929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53445254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226473864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15556753

Total number of triples: 77.